The Centers for Medicare and Medicaid Services are being urged to make changes that could improve savings for patients and health care payers, as well as expand patient access to biosimilars. READ MORE

From The Journal

This report reviews the complex nature of multiple myeloma treatment, the current landscape of clinical practice guidelines and treatment pathways, and economic considerations for treatment. READ MORE
September 8-12 marked the annual European Society for Medical Oncology (ESMO) Congress. Cancer researchers and clinicians came together in Madrid, Spain to enable collaboration and the exchange of important ideas in oncology. Journal of Clinical Pathways has provided some of the most relevant discussions from the congress. READ MORE
Journal of Clinical Pathways spoke with Jennifer Singleterry, MA about the role of financial navigators in the oncology landscape and strategies for greater global insurance literary across the spectrum. READ MORE
Annual updates to formulary exclusion lists suggest a need for careful evaluation by benefit sponsors, clinicians, patient advocacy groups, and the pharmaceutical industry to determine implications on treatment outcomes and achieving value-based care. READ MORE